Evidence map›Paper›PMID 30515427›Full record

ArticleOpen forum infectious diseases2018

Inflammatory Mediator Expression Associated With Antibody Response Induced by Live Attenuated vs Inactivated Influenza Virus Vaccine in Children.

Judith M Martin, Raghunandan Avula, Mary Patricia Nowalk, Chyongchiou Jeng Lin, William T Horne, Uma R Chandran, Jennifer P Nagg, Richard K Zimmerman, Kelly S Cole, John F Alcorn

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Judith M MartinDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Raghunandan AvulaDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mary Patricia NowalkDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Chyongchiou Jeng LinDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
William T HorneDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Uma R ChandranDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Jennifer P NaggDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Richard K ZimmermanDepartment of Family Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Kelly S ColeCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania.
John F AlcornDepartment of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania.
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse networkU01IP001035 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2016 to 2020
$7.8M
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a LargeU01IP000467 · IP · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ZIMMERMAN, RICHARD K · 2011 to 2015
$5.9M
ACL HHS U01IP001035NCATS NIH HHS UL1 TR001857NCIRD CDC HHS U01 IP000467NCIRD CDC HHS U01 IP001035
6 · The paper itself

Abstract

backgroundThe reasons for differences in vaccine effectiveness between live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) are not clear.

methodsBlood samples were obtained before vaccination and at days 7 and 21 postvaccination with 2015-2016 quadrivalent IIV or LAIV. Serologic response to the vaccine was measured by hemagglutination inhibition assay. Targeted RNA sequencing and serum cytokine analysis were performed. Paired analyses were used to determine gene expression and were compared between IIV and LAIV recipients. Classification And Regression Trees analysis (CART) identified the strongest associations with vaccine response.

resultsForty-six enrollees received IIV, and 25 received LAIV. The mean age was 11.5 (±3.7) years. Seroconversion with IIV was associated with changes in expression of

conclusionsDistinct markers of seroconversion and seroprotection against IIV and LAIV were identified using immunophenotyping and CART analysis.

Indexed as

antibodiescytokinesinfluenza vaccineRNA seq

Identifiers

PMID30515427
PMCPMC6262113
OpenAlexW2898117107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.